SC Filed 2019-03-19 Event — SEC 0001144204-19-014888 →

Dexxon Holdings Ltd. → Axovant Sciences Ltd.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

16 13D/G filings on this issuer

15 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Axovant Sciences Ltd.

Filed	Form	Filer	Stake	Shares
2019-12-31	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-17	SC	Lo Andrew	—	—	view →
2019-07-16	SC	Machado Patrick	—	—	view →
2019-07-16	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-12	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2019-07-12	SC	Dexxon Holdings Ltd.	—	—	view →
2019-07-12	SC	QVT Financial LP	—	—	view →
2019-07-12	SC	SVF Investments (UK) Ltd	—	—	view →
2019-03-19	SC	Machado Patrick	—	—	view →
2019-03-19	SC	Roivant Sciences Ltd.	—	—	view →
2019-03-19	SC	QVT Financial LP	—	—	view →
2019-03-19	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2019-03-19	SC	Lo Andrew	—	—	view →
2019-03-19	SC	SVF Investments (UK) Ltd	—	—	view →
2019-01-03	SC	VIKING GLOBAL INVESTORS LP	—	—	view →

Other Filings by Dexxon Holdings Ltd.

Filed	Form	Issuer	Stake	Shares
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-07-12	SC	Myovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-01-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →